User:Blent/Seminar 07 fall: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
Line 19: Line 19:
* [http://www.nature.com/nature/journal/v428/n6982/full/428486a.html Medical genetics: a marker for Stevens-Johnson syndrome, 2004 April Nature]
* [http://www.nature.com/nature/journal/v428/n6982/full/428486a.html Medical genetics: a marker for Stevens-Johnson syndrome, 2004 April Nature]
** HLA-B 1520 is an universal marker for Han Chinese in Taiwan
** HLA-B 1520 is an universal marker for Han Chinese in Taiwan
** [http://brc.se.fju.edu.tw/protein/analysis/ms.htm MS蛋白質序列分析]
* [http://www.nature.com/tpj/journal/v6/n4/full/6500356a.html A marker for Stevens-Johnson syndrome ...: ethnicity matters, 2006 The Pharmacogenomics Journal]
* [http://www.nature.com/tpj/journal/v6/n4/full/6500356a.html A marker for Stevens-Johnson syndrome ...: ethnicity matters, 2006 The Pharmacogenomics Journal]
** HLA-B 1502 may '''NOT''' be an universal marker for CBZ-SJS
** HLA-B 1502 may '''NOT''' be an universal marker for CBZ-SJS

Revision as of 22:46, 1 October 2007

Title

  • Toward Personalized Medicine in BMI-based Methodology: A case study of Carbamazepine and challenges in the future

Outlines (Sep 30, 2007)

What is personalized medicine

case study: CBZ-SJS

case study: Warfarin (抗凝血劑) and dosage estimation

case study: Diabetes and Diagnosis

BioBank and Biomarkers discovery

case study: The First race-specific drug BiDil

ELSI, Biobank and FDA guide lines

Movies

Outlines (Sep 20, 2007)

  • BMI = BI + MI
    • what BMI can do
      • Neuroinformatics (NI)
      • Cancer research (CR)
  • Personalized Medicine (PM)

Background

Materials

Notes